Search for Clinical Trial Results
Oligodendroglioma - 253 Studies Found
| Status | Study |
| Completed |
Study Name: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial Condition:
Date: 2013-04-29 Interventions: Drug: Temozolomide Temozolomide 200 mg/m2/d in a fasting state for 5 consecutive days (1,000 mg/m2 per 2 |
| Completed |
Study Name: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma Condition:
Date: 2006-08-08 Interventions: Drug: Temozolomide p.o.(by mouth), 150 mg/m2/d x days 1-7 |
| Completed |
Study Name: Temozolomide in Treating Patients With Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions: Drug: temozolomide |
| Active, not recruiting |
Study Name: Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Condition:
Date: 2006-11-16 Interventions: Drug: temozolomide Schedule of Temozolomide administration: Temozolomide, 150 mg/m2/d x days 1-7 and 15- |
| Completed |
Study Name: Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
| Active, not recruiting |
Study Name: Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas Condition: Brain and Central Nervous System Tumors Date: 2002-04-09 Interventions:
|
| Completed |
Study Name: Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
| Active, not recruiting |
Study Name: Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma Condition:
Date: 2007-12-22 Interventions: Drug: temozolomide followed by high dose busulfan and thiotepa Temozolomide 200mg/m2 PO Days 1-5 recycle |
| No longer available |
Study Name: Expanded Access to ANG1005 for Individual Patients Condition:
Interventions: Drug: ANG1005 |
| Recruiting |
Study Name: Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors Condition:
Interventions: |